Biomea Fusion Inc (BMEA)
5.215
-0.34
(-6.04%)
USD |
NASDAQ |
Jun 25, 16:00
5.215
0.00 (0.00%)
After-Hours: 20:00
Biomea Fusion Cash and Short Term Investments (Quarterly): 144.92M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 144.92M |
| December 31, 2023 | 176.87M |
| September 30, 2023 | 199.09M |
| June 30, 2023 | 222.91M |
| March 31, 2023 | 86.30M |
| December 31, 2022 | 113.05M |
| September 30, 2022 | 133.46M |
| Date | Value |
|---|---|
| June 30, 2022 | 149.63M |
| March 31, 2022 | 164.81M |
| December 31, 2021 | 173.52M |
| September 30, 2021 | 189.40M |
| June 30, 2021 | 198.57M |
| March 31, 2021 | 45.48M |
| December 31, 2020 | 61.70M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
45.48M
Minimum
Mar 2021
222.91M
Maximum
Jun 2023
147.12M
Average
157.22M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Geron Corp | 443.05M |
| Poseida Therapeutics Inc | 198.65M |
| Asensus Surgical Inc | 7.989M |
| Geovax Labs Inc | 0.7689M |
| Syndax Pharmaceuticals Inc | 443.16M |